Entry mechanism, trafficking and localisation of Macrobrachium rosenbergii (De Man, 1879) nodavirus in SF9 insect cells
Macrobrachium rosenbergii nodavirus (MrNv) is a Gammanodavirus that was isolated from infected giant freshwater prawn juveniles. MrNv is the major cause of white tail disease (WTD) in prawn hatcheries and the mortality of the infected post-larvae is 100% in just 3 days. Vertical transmission and...
Saved in:
Main Author: | |
---|---|
Format: | Thesis |
Language: | English |
Published: |
2015
|
Subjects: | |
Online Access: | http://psasir.upm.edu.my/id/eprint/67056/1/FBSB%202016%2042%20IR.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Macrobrachium rosenbergii nodavirus (MrNv) is a Gammanodavirus that was isolated
from infected giant freshwater prawn juveniles. MrNv is the major cause of white tail
disease (WTD) in prawn hatcheries and the mortality of the infected post-larvae is
100% in just 3 days. Vertical transmission and widen host range contribute to a
worldwide economical crisis. No effective treatments are available to stop the virus
infection. This study was aimed to identify the trafficking mechanism involved in
MrNv infection and its localisation in the infected cells by using the virus-like particles
(VLPs) of MrNv. The RNA2 of MrNv that codes for the viral capsid was previously
cloned into pTrcHis2-TOPO expression vector. The recombinant MrNv capsid
(MrNvc) protein with the size of about 46 kDa produced VLPs in Escherichia coli with
undistinguishable properties from the native MrNv. These VLPs were used to study the
entry mechanism, trafficking and localisation of the MrNv in Sf9 insect cells. Live cell
observation using the live cell imaging system (LCIS) revealed that the internalisation
of MrNvc VLPs was initiated by VLPs binding to the cell surface. Ammonium chloride
inhibition study and LCIS showed that the MrNvc VLPs entry was mediated by acidic
endosomal pathway. The number of the green fluorescent granules in Sf9 cells
incubated with MrNvc VLPs decreased in the presence of 0.1 mM and 1.0 mM NH4Cl
which blocks the endosomal acidification. From LCIS data, green fluorescent ‘ring-like
shape’ was observed as a result of attached VLPs being accumulated around the
membrane pits. Green granules of endosomes enclosing VLPs were produced and later,
the shape and size of the endosomes become disproportionate. The VLPs escape from
the endosomal membrane when the fluorescent green granules faded and disappeared.
MrNvc VLPs localised in the cell cytoplasm and nucleus as spotted from the Z-stack
images of the fluorescence microscopy and the Western blotting of the Sf9 sub-cellular
fractionation. His-tag located at the C-terminal end of the MrNvc can still be detected
by anti-His antibody suggesting that MrNvc is still intact upon internalisation and nuclear translocation. The mutants of the N-terminally truncated capsid proteins
[9ΔMrNvc, 19ΔMrNvc 29ΔMrNvc and (20-29)ΔMrNvc] were used to study the
function of the N-terminal residues in nuclear translocation. The 29ΔMrNvc and (20-
29)ΔMrNvc without the positively-charged RNA-binding region (20KRRKRSRRNR29)
showed no effect in VLPs entry into Sf9 cells but these mutants were found much
lesser in the cell nucleus. This study revealed that MrNvc internalised Sf9 cells by
receptor-mediated endocytosis and localised in the cell cytoplasm and nucleus. The
endosomal escape mechanism of MrNv is different from that of Flock House virus
(FHV), a model for non-enveloped virus entry, which involves gamma (γ) peptide
cleavage at the C-terminal end of its capsid protein. It is suggested that
20KRRKRSRRNR29 sequence has dual function as RNA-binding sequence and nuclear
targeting sequence of MrNv. This close up examinations on the cellular level of MrNv
infection will contribute to its elimination and control in giant freshwater prawn
farming. Understanding the mechanism involved in MrNvc VLPs internalisation,
trafficking and localisation in its host’s cell will be useful for other studies such as drug
nano-delivery, gene transfer and vaccine development. |
---|